TABLE 2.
Gene(s) | Growth (%) on plates with the following avilamycin concn (μg/ml):
|
|||||||
---|---|---|---|---|---|---|---|---|
0 | 5 | 10 | 20 | 50 | 100 | 150 | 250 | |
Control | 100 ± 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
aviABC1 plus aviABC2 | 100 ± 10 | 17 ± 2 | 0 | 0 | 0 | 0 | 0 | 0 |
aviRa | 100 ± 15 | 21 ± 0.5 | 10 ± 1 | 0 | 0 | 0 | 0 | 0 |
aviRb | 100 ± 15 | 78 ± 4 | 68 ± 5 | 47 ± 7 | 44 ± 5 | 39 ± 4 | 32 ± 3 | 6 ± 1.5 |
aviRa plus aviRb | 100 ± 15 | 100 ± 15 | 100 ± 12 | 100 ± 10 | 100 ± 15 | 100 ± 13 | 100 ± 9 | 51 ± 11 |
aviRa plus aviRb plus aviABC1/2 | 100 ± 1 | 100 ± 16 | 100 ± 16 | 100 ± 12 | 100 ± 10 | 100 ± 13 | 100 ± 8 | 68 ± 13 |